Mosaic Biomedicals

Mosaic Therapeutics

The company develops targeted oncology drug combinations and biomarker-defined therapies for cancer patients and healthcare providers.

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.

Swarm Oncology

This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

Alyssum Therapeutics

This company develops B cell-based targeted immunotherapies for patients with solid tumours and complex immunological conditions.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

Iscaff Pharma

This company develops patient-derived tumor scaffolds for pharmaceutical firms to improve the pre-clinical validation and development of aggressive cancer treatments.

CTRL Therapeutics

This company develops cell therapies for solid tumours and microfluidic platforms to identify rare tumour-reactive lymphocytes for cancer patients.